Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1 - PubMed (original) (raw)
Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1
Matt J Neville et al. Hum Mutat. 2004 Jun.
Abstract
The dopamine D2 receptor has been extensively studied in relation to alcoholism, substance abuse, and nicotine dependence. The most frequently examined polymorphism linked to this gene is the Taq1A restriction fragment length polymorphism (RFLP) (dbSNP rs1800497; g.32806C>T in GenBank AF050737.1), which has been associated with a reduction in D2 receptor density, although this is not universally accepted. The Taq1A RFLP lies 10 kB downstream of DRD2 and may therefore fall within a different coding region than the DRD2 gene or within a regulatory region. Within this downstream region, we have identified a novel kinase gene, named ankyrin repeat and kinase domain containing 1 (ANKK1), which contains a single serine/threonine kinase domain and is expressed at low levels in placenta and whole spinal cord RNA. This gene is a member of an extensive family of proteins involved in signal transduction pathways. The DRD2 Taq1A RFLP is a single nucleotide polymorphism (SNP) that causes an amino acid substitution within the 11th ankyrin repeat of ANKK1 (p.Glu713Lys), which, while unlikely to affect structural integrity, may affect substrate-binding specificity. If this is the case, then changes in ANKK1 activity may provide an alternative explanation for previously described associations between the DRD2 Taq1A RFLP and neuropsychiatric disorders such as addiction.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
- Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution.
Doehring A, Hentig Nv, Graff J, Salamat S, Schmidt M, Geisslinger G, Harder S, Lötsch J. Doehring A, et al. Pharmacogenet Genomics. 2009 Jun;19(6):407-14. doi: 10.1097/FPC.0b013e328320a3fd. Pharmacogenet Genomics. 2009. PMID: 19373123 - [ANKK1 gene in psychiatry].
Suchanecka A, Grzywacz A, Samochowiec J. Suchanecka A, et al. Psychiatr Pol. 2011 May-Jun;45(3):349-56. Psychiatr Pol. 2011. PMID: 22232965 Review. Polish. - Genetic diagnostics of functional variants of the human dopamine D2 receptor gene.
Doehring A, Kirchhof A, Lötsch J. Doehring A, et al. Psychiatr Genet. 2009 Oct;19(5):259-68. doi: 10.1097/YPG.0b013e32832d0941. Psychiatr Genet. 2009. PMID: 19512960 - Family-based association analyses of alcohol dependence phenotypes across DRD2 and neighboring gene ANKK1.
Dick DM, Wang JC, Plunkett J, Aliev F, Hinrichs A, Bertelsen S, Budde JP, Goldstein EL, Kaplan D, Edenberg HJ, Nurnberger J Jr, Hesselbrock V, Schuckit M, Kuperman S, Tischfield J, Porjesz B, Begleiter H, Bierut LJ, Goate A. Dick DM, et al. Alcohol Clin Exp Res. 2007 Oct;31(10):1645-53. doi: 10.1111/j.1530-0277.2007.00470.x. Alcohol Clin Exp Res. 2007. PMID: 17850642 - Ankyrin Repeat and Kinase Domain Containing 1 Gene, and Addiction Vulnerability.
Koeneke A, Ponce G, Troya-Balseca J, Palomo T, Hoenicka J. Koeneke A, et al. Int J Mol Sci. 2020 Apr 4;21(7):2516. doi: 10.3390/ijms21072516. Int J Mol Sci. 2020. PMID: 32260442 Free PMC article. Review.
Cited by
- Large-scale exome sequencing identified 18 novel genes for neuroticism in 394,005 UK-based individuals.
Wu XR, Li ZY, Yang L, Liu Y, Fei CJ, Deng YT, Liu WS, Wu BS, Dong Q, Feng JF, Cheng W, Yu JT. Wu XR, et al. Nat Hum Behav. 2024 Nov 7. doi: 10.1038/s41562-024-02045-w. Online ahead of print. Nat Hum Behav. 2024. PMID: 39511343 - ANKK1 Is a Wnt/PCP Scaffold Protein for Neural F-ACTIN Assembly.
Domínguez-Berzosa L, Cantarero L, Rodríguez-Sanz M, Tort G, Garrido E, Troya-Balseca J, Sáez M, Castro-Martínez XH, Fernandez-Lizarbe S, Urquizu E, Calvo E, López JA, Palomo T, Palau F, Hoenicka J. Domínguez-Berzosa L, et al. Int J Mol Sci. 2024 Oct 4;25(19):10705. doi: 10.3390/ijms251910705. Int J Mol Sci. 2024. PMID: 39409035 Free PMC article. - Leveraging the Genetics of Psychiatric Disorders to Prioritize Potential Drug Targets and Compounds.
Parker N, Koch E, Shadrin AA, Fuhrer J, Hindley GFL, Stinson S, Jaholkowski P, Tesfaye M, Dale AM, Wingo TS, Wingo AP, Frei O, O'Connell KS, Smeland OB, Andreassen OA. Parker N, et al. medRxiv [Preprint]. 2024 Sep 24:2024.09.24.24314069. doi: 10.1101/2024.09.24.24314069. medRxiv. 2024. PMID: 39399035 Free PMC article. Preprint. - Relationship of Genetic Polymorphisms and Microbial Composition with Binge Eating Disorder: A Systematic Review.
Monserrat Hernández M, Jiménez-Rodríguez D. Monserrat Hernández M, et al. Healthcare (Basel). 2024 Jul 19;12(14):1441. doi: 10.3390/healthcare12141441. Healthcare (Basel). 2024. PMID: 39057584 Free PMC article. Review. - The association of genetic polymorphisms within the dopaminergic system with nicotine dependence: A narrative review.
Yang J, Wang H, Chen H, Hou H, Hu Q. Yang J, et al. Heliyon. 2024 Jun 15;10(12):e33158. doi: 10.1016/j.heliyon.2024.e33158. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 39021905 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases